Researchers at the University of Chicago have captured complete images of adhesion G protein-coupled receptors and an ...

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with ...

This study demonstrates the development of PAGERs (programmable antigen-gated engineered receptors), combining antigen ...

Micro-cap early-stage biotech Exicure, Inc.’s ($XCUR) shares rose sharply in premarket trading on Friday following a deal to ...

结果显示，虽然AlphaFold3在预测整体GPCR骨架结构方面比AlphaFold2表现出更好的性能，但在配体（尤其是离子、多肽和蛋白质）结合方面，预测结果与实验结果之间仍然存在显著差异。该研究还评估了预测结构在各种配体类型中的准确性，量化了结合口 ...

New research from the University of Chicago combines two powerful imaging techniques to study the complete structure of a ...

Researchers at the University of Chicago have successfully captured detailed images of adhesion G protein-coupled receptors, ...

After years of restructuring, Chicago-based Exicure has South Korean majority ownership and is buying the U.S. arm of a South Korean oncology biotech firm.

Almost 35% of drugs approved by the Food and Drug Administration work by targeting G protein-coupled receptors (GPCRs), proteins embedded in cell membranes that allow cells to communicate with ...

The company’s lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 ...

Two types of amylin-based treatments for the treatment of obesity are currently being developed: dual amylin and calcitonin receptor agonists (DACRAs) that target both the amylin and calcitonin ...

Principal Financial Group Inc. increased its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 230.0% in the third quarter, according to the company in its most recent ...